Your browser doesn't support javascript.
loading
Berberine mitigates hepatic insulin resistance by enhancing mitochondrial architecture via the SIRT1/Opa1 signalling pathway.
Xu, Jia; Zhang, Yining; Yu, Zhiyi; Guan, Yueqi; Lv, Yuqian; Zhang, Meishuang; Zhang, Ming; Chen, Li; Lv, Xiaoyan; Guan, Fengying.
Afiliação
  • Xu J; Department of Pharmacology, School of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Zhang Y; Department of Pediatric Endocrinology, the First Clinical Hospital Affiliated to Jilin University, Changchun 130021, China.
  • Yu Z; Department of Pharmacology, School of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Guan Y; Department of Pharmacology, School of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Lv Y; Department of Pharmacology, School of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Zhang M; Department of Pharmacology, School of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Zhang M; Department of Pharmacology, School of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Chen L; Department of Pharmacology, School of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Lv X; Department of Clinical Laboratory, the Second Clinical Hospital Affiliated to Jilin University, Changchun 130041, China.
  • Guan F; Department of Pharmacology, School of Basic Medical Sciences, Jilin University, Changchun 130021, China.
Acta Biochim Biophys Sin (Shanghai) ; 54(10): 1464-1475, 2022 Oct 25.
Article em En | MEDLINE | ID: mdl-36269134

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Berberina / Resistência à Insulina Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Berberina / Resistência à Insulina Idioma: En Ano de publicação: 2022 Tipo de documento: Article